Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBITDA Margin (2021 - 2025)

Stemtech's EBITDA Margin history spans 6 years, with the latest figure at 14.91% for Q3 2025.

  • On a quarterly basis, EBITDA Margin rose 20382.0% to 14.91% in Q3 2025 year-over-year; TTM through Sep 2025 was 3.9%, a 12227.0% increase, with the full-year FY2024 number at 81.25%, up 2018.0% from a year prior.
  • EBITDA Margin hit 14.91% in Q3 2025 for Stemtech, down from 55.76% in the prior quarter.
  • Over the last five years, EBITDA Margin for STEK hit a ceiling of 1624.65% in Q3 2022 and a floor of 1925.71% in Q2 2022.
  • Historically, EBITDA Margin has averaged 104.48% across 5 years, with a median of 48.22% in 2024.
  • The widest YoY moves for EBITDA Margin: up 226213bps in 2022, down -189688bps in 2022.
  • Tracing STEK's EBITDA Margin over 5 years: stood at 44.53% in 2021, then soared by 81bps to 8.59% in 2022, then plummeted by -938bps to 89.08% in 2023, then skyrocketed by 131bps to 27.85% in 2024, then plummeted by -154bps to 14.91% in 2025.
  • Business Quant data shows EBITDA Margin for STEK at 14.91% in Q3 2025, 55.76% in Q2 2025, and 89.09% in Q1 2025.